Arbutus Biopharma Corp

ABUS | NASDAQ

Price Alert Chart Builder DCF Calculator

-$0.01 (-0.20%)

At close: Sep 21, 2026, 4:00 PM ET

$4.98

-$0.02 (-0.40%)

Pre-market: Sep 22, 2026, 8:47 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Cash & Equivalents	19.17M	23.71M	18.01M	22.41M	37.41M	37.08M	36.33M	31.85M	62.79M	43.1M	26.29M	17.53M	27.2M	40.57M	30.78M	24M	47.32M	81.33M	109.28M	77.88M	30.95M	79.42M
Short-Term Investments	73.45M	71.52M	73.46M	71.29M	60.68M	75.63M	86.29M	95.95M	79.2M	86.14M	99.72M	116.65M	125.29M	106.15M	116.14M	110.71M	102.88M	84.15M	46.04M	43.52M	47.43M	52.54M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.96M	6.53M	8.68M	6.28M	10.5M	11.06M	31.79M	37.36M	55.44M	50.45M	56.32M	35.69M	30.53M	42.91M	n/a
Other Long-Term Assets	132K	131K	130K	131K	n/a	34K	34K	n/a	n/a	n/a	n/a	3K	11K	62K	103K	167K	180K	190K	61K	n/a	n/a	n/a
Receivables	179.74M	1.31M	1.75M	905K	1.02M	1.18M	2.41M	1.61M	2.07M	2.14M	1.78M	2.77M	3.21M	2.66M	1.35M	1.84M	1.97M	1.31M	899K	1.67M	1.3M	1.27M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	180.47M	1.24M	300K	100K	2.92M	2.28M	300K	4.17M	600K	4.25M	4.66M	3.1M	600K	2.87M	n/a	5.62M	5.91M	n/a	n/a	n/a	n/a
Total Current Assets	273.88M	277.01M	94.46M	97.44M	103.12M	116.81M	127.32M	132.78M	148.22M	135.87M	132.03M	141.61M	158.8M	152.85M	151.14M	141.14M	157.79M	172.7M	160.66M	126.54M	83.47M	137.34M
Property-Plant & Equipment	10K	22K	32K	137K	148K	168K	4.36M	4.7M	5.3M	5.74M	6.09M	6.54M	6.96M	6.52M	6.81M	7.06M	7.42M	7.67M	8.07M	8.53M	9M	8.9M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	142K	153K	162K	268K	148K	202K	4.39M	7.66M	11.82M	14.42M	12.37M	17.03M	18.02M	38.37M	44.28M	62.67M	58.05M	64.18M	43.82M	39.06M	51.91M	8.9M
Total Assets	274.03M	277.16M	94.62M	97.71M	103.27M	117.01M	131.71M	140.44M	160.04M	150.29M	144.4M	158.64M	176.82M	191.22M	195.42M	203.8M	215.84M	236.88M	204.49M	165.6M	135.38M	146.24M
Account Payables	2.85M	1.46M	1.17M	1.01M	1.32M	2.24M	2.32M	2.32M	2.65M	3.74M	3.22M	2.26M	1.04M	2.46M	3.52M	872K	n/a	1.19M	3.17M	1.04M	2.06M	355K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	6.76M	7.57M	10.91M	11.03M	n/a	11.79M	n/a	n/a	n/a	16.46M	n/a	16.97M	23.26M	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	547K	n/a	n/a	n/a	n/a	n/a	453K	n/a	n/a	n/a	n/a	n/a	372K	n/a	377K	439K	383K	n/a	357K	432K
Other Current Liabilities	n/a	245K	2.13M	763K	768K	5.97M	2.32M	565K	5.98M	11.55M	3.7M	12.11M	15.33M	15.06M	8.78M	14.88M	9.84M	6.08M	3.39M	n/a	4.57M	5.01M
Total Current Liabilities	3.36M	5.11M	6.01M	5.18M	5.02M	19.43M	15.62M	18.92M	22.6M	20.3M	22.49M	22.32M	24.53M	25.15M	32.86M	27.51M	29.82M	32.41M	11.22M	10.11M	8.84M	6.69M
Long-Term Debt	3.11M	3.28M	3.44M	3.68M	3.91M	4.41M	4.83M	5.32M	5.86M	6.4M	6.95M	8.11M	8.79M	9.38M	10.37M	12.32M	14.23M	15.44M	16.3M	17.88M	18.98M	19.37M
Other Long-Term Liabilities	8.82M	8.6M	8.4M	11.05M	10.78M	10.52M	10.23M	8.34M	7.99M	7.78M	7.6M	7.37M	7.17M	11.1M	7.53M	16.51M	5.71M	5.5M	5.3M	5.11M	4.25M	3.56M
Total Long-Term Liabilities	11.93M	11.88M	12.04M	15.13M	15.27M	18.42M	18.72M	14.63M	14.99M	15.36M	15.9M	16.98M	17.6M	22.16M	25.71M	30.78M	32.87M	38.62M	23.83M	25.34M	25.71M	25.4M
Total Liabilities	15.29M	16.99M	18.04M	20.31M	20.29M	37.85M	34.34M	33.55M	37.59M	35.65M	38.38M	39.3M	42.13M	47.31M	58.57M	58.28M	62.69M	71.03M	35.05M	35.46M	34.55M	32.09M
Total Debt	3.63M	3.91M	4.19M	4.61M	5M	5.6M	6.12M	6.76M	7.46M	8.08M	8.72M	10.02M	10.83M	11.5M	12.55M	14.63M	16.7M	17.98M	18.91M	20.62M	21.81M	22.28M
Book Value	258.73M	260.18M	76.58M	77.4M	82.98M	79.16M	97.37M	106.89M	122.45M	114.64M	106.02M	119.34M	134.69M	143.92M	136.85M	145.52M	153.14M	165.85M	169.44M	130.14M	100.83M	114.15M
Book Value Per Share	1.31	1.33	0.40	0.40	0.43	0.42	0.51	0.57	0.65	0.65	0.63	0.71	0.81	0.89	0.89	0.96	1.03	1.12	1.67	1.28	1.04	1.22
Common Stock	1.45B	1.44B	1.42B	1.42B	1.42B	1.42B	1.41B	1.41B	1.4B	1.38B	1.35B	1.35B	1.34B	1.34B	1.32B	1.31B	1.3B	1.3B	1.29B	1.07B	1.02B	1.01B
Retained Earnings	-1.22B	-1.21B	-1.38B	-1.38B	-1.37B	-1.37B	-1.35B	-1.33B	-1.31B	-1.29B	-1.28B	-1.26B	-1.24B	-1.22B	-1.2B	-1.18B	-1.16B	-1.15B	-1.13B	-1.11B	-1.09B	-1.07B
Comprehensive Income	-48.24M	-48.2M	-48.1M	-48.13M	-48.19M	-48.17M	-48.14M	-48.09M	-48.31M	-48.37M	-48.42M	-48.88M	-49.47M	-49.63M	-50.49M	-51M	-50.1M	-49.41M	-48.33M	-48.19M	-48.2M	-48.17M
Shareholders Equity	258.73M	260.18M	76.58M	77.4M	82.98M	79.16M	97.37M	106.89M	122.45M	114.64M	106.02M	119.34M	134.69M	143.92M	136.85M	145.52M	153.14M	165.85M	169.44M	130.14M	100.83M	114.15M
Total Investments	73.45M	71.52M	73.46M	71.29M	60.68M	75.63M	86.29M	98.91M	85.73M	94.82M	106M	127.15M	136.34M	137.94M	153.5M	166.15M	153.33M	140.47M	81.72M	74.05M	90.33M	52.54M